the lack of a potent and specific cholecystokinin ( cck ) receptor antagonist has greatly hampered studies of the role of cck in controlling pancreatic growth , enzyme release , pancreatitis , and pancreatic carcinoma .
C0030274
pancreatic
C0235974
pancreatic carcinoma